Oncology Institute(The)'s current cash is $41M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for TOI is $41M as of June 2026. That compares with $30M in the prior-year period — up 35.7% year over year. Investors often review this figure alongside Oncology Institute(The)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, TOI's current cash moved from $30M to $41M — a 35.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Oncology Institute(The)'s operating scale or balance-sheet position.
A current cash figure of $41M for TOI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting TOI's current cash ($41M), review year-over-year change from $30M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.